Many Americans not getting breast, cervical, colon cancer screenings
the ONA take:
According to a study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, researchers have found that many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Specifically, results showed that among adults in the age groups recommended for screening, approximately one in four women not up to date with breast cancer screening, one in five women were not up to date with cervical cancer screening, and two in five were not up to date with colon cancer screening.
Of note, colon cancer screening rates were stagnant from 2010 to 2013 and cervical cancer screening using the Pap test in women 21 to 65 years of age was lower in 2013 than in 2000. In addition, mammography screenings changed minimally from previous years.
"It is often difficult to get patients to comply with screening tests, especially when they are uninsured or underinsured," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. However, healthcare providers need to convince patients that early screening can improve outcomes.
Many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|